Stonepine Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
100,000
+78,450
| +364% | +$887K | 1.11% | 24 |
|
|
2025
Q1 | $249K | Buy |
+21,550
| New | +$249K | 0.24% | 46 |
|
|
2021
Q4 | – | Sell |
-200,000
| Closed | -$3.49M | – | 30 |
|
|
2021
Q3 | $3.49M | Hold |
200,000
| – | – | 1.59% | 15 |
|
|
2021
Q2 | $4.79M | Sell |
200,000
-222,310
| -53% | -$5.33M | 2.51% | 14 |
|
|
2021
Q1 | $10.8M | Buy |
+422,310
| New | +$10.8M | 5.86% | 5 |
|
|
2019
Q4 | – | Sell |
-33,033
| Closed | -$383K | – | 27 |
|
|
2019
Q3 | $383K | Buy |
+33,033
| New | +$383K | 0.37% | 21 |
|
|
2018
Q4 | – | Sell |
-138,100
| Closed | -$3.05M | – | 25 |
|
|
2018
Q3 | $3.05M | Buy |
+138,100
| New | +$3.05M | 1.79% | 17 |
|